In Luminal B HER2 cancers, a significantly increased hazard ratio is seen in Trast –ve patients: DFS (HR 3.82, 95% CI 1.5–9.4; p = 0.004) and OS (HR 2.49, 95% CI 1.1–5.6; p = 0.03). Here, ERBB2 is linked to cancer.